Usefulness of Triglyceride-glucose index for detecting prevalent atrial fibrillation in a type 2 diabetic population

References

• Wang L, Ze F, Li J, et al. Trends of global burden of atrial fibrillation/flutter from global burden of disease study 2017. Heart. 2021 Jun;107(11):881–887.
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association of cardio-thoracic surgery (EACTS). Eur Heart J. 2020 Aug 29;42(5):373–498.
   Web of Science ®Google Scholar
• Bell DSH, Goncalves E. Atrial fibrillation and type 2 diabetes: prevalence, etiology, pathophysiology and effect of anti-diabetic therapies. Diabetes Obes Metab. 2019 Feb;21(2):210–217.
   PubMed Web of Science ®Google Scholar
• Huxley RR, Filion KB, Konety S, et al. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol. 2011 Jul 1;108(1):56–62.
   PubMed Web of Science ®Google Scholar
• Kumar P, Gehi AK. atrial fibrillation and metabolic syndrome: understanding the connection. J Atr Fibrillation. 2012 Oct-Nov;5(3):647.
   PubMedGoogle Scholar
• Goudis CA, Korantzopoulos P, Ntalas IV, et al. Diabetes mellitus and atrial fibrillation: pathophysiological mechanisms and potential upstream therapies. Int J Cardiol. 2015 Apr 1;184:617–622.
   PubMed Web of Science ®Google Scholar
• Lee Y, Cha SJ, Park JH, et al. Association between insulin resistance and risk of atrial fibrillation in non-diabetics. Eur J Prev Cardiol. 2020 Dec;27(18):1934–1941.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang YJ, Liu ZY, et al. Effect of insulin resistance on recurrence after radiofrequency catheter ablation in patients with atrial fibrillation. Cardiovasc Drugs Ther. 2022 Feb 26.
   Web of Science ®Google Scholar
• Chan Y, Chang G, Lai Y, et al. Atrial fibrillation and its arrhythmogenesis associated with insulin resistance. Cardiovasc Diabetol. 2019;18(1):125.
   PubMed Web of Science ®Google Scholar
• Kim JK. Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo. Methods Mol Biol. 2009;560:221–238.
   PubMedGoogle Scholar
• Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008 Dec;6(4):299–304.
   PubMedGoogle Scholar
• Guerrero-Romero F, Simental-Mendía L, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–3351.
   PubMed Web of Science ®Google Scholar
• Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, et al. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189–197.
   PubMed Web of Science ®Google Scholar
• Zheng R, Mao Y. Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study. Lipids Health Dis. 2017 Sep 13;16(1):175.
   PubMed Web of Science ®Google Scholar
• Park K, Ahn CW, Lee SB, et al. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019 Aug;42(8):1569–1573.
   PubMed Web of Science ®Google Scholar
• Lv L, Zhou Y, Chen X, et al. Relationship between the tyg index and diabetic kidney disease in patients with type-2 diabetes mellitus. Diabetes Metab Syndr Obes. 2021;14:3299–3306.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang W, Ning G. Metabolic management center: an innovation project for the management of metabolic diseases and complications in China. J Diabetes. 2019 Jan;11(1):11–13.
   PubMed Web of Science ®Google Scholar
• Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003 Jan;26(Suppl 1):S5–20.
   PubMed Web of Science ®Google Scholar
• Pan X, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9(6):373–392.
   PubMed Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama. 2014 Feb 5;311(5):507–520.
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen Z, Wang X, et al. The disease burden of atrial fibrillation in China from a national cross-sectional survey. Am J Cardiol. 2018 Sep 1;122(5):793–798.
   PubMed Web of Science ®Google Scholar
• Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007 Feb 20;115(7):928–935.
   PubMed Web of Science ®Google Scholar
• Pickering JW, Endre ZH. New metrics for assessing diagnostic potential of candidate biomarkers. Clin J Am Soc Nephrol. 2012 Aug;7(8):1355–1364.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB Sr., D’Agostino RB Jr., et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008 Jan 30;27(2):157–172. discussion 207-12.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011 Jan 15;30(1):11–21.
   PubMed Web of Science ®Google Scholar
• Grunkemeier GL, Jin R. Net reclassification index: measuring the incremental value of adding a new risk factor to an existing risk model. Ann Thorac Surg. 2015 Feb;99(2):388–392.
   PubMed Web of Science ®Google Scholar
• Wei Z, Zhu E, Ren C, et al. Triglyceride-glucose index independently predicts new-onset atrial fibrillation after septal myectomy for hypertrophic obstructive cardiomyopathy beyond the traditional risk factors. Front Cardiovasc Med. 2021;8:692511.
   PubMed Web of Science ®Google Scholar
• Ling Y, Fu C, Fan Q, et al. Triglyceride-glucose index and new-onset atrial fibrillation in st-segment elevation myocardial infarction patients after percutaneous coronary intervention. Front Cardiovasc Med. 2022;9:838761.
   PubMed Web of Science ®Google Scholar
• Tang Q, Guo XG, Sun Q, et al. The pre-ablation triglyceride-glucose index predicts late recurrence of atrial fibrillation after radiofrequency ablation in non-diabetic adults. BMC Cardiovasc Disord. 2022 May 14;22(1):219.
   PubMed Web of Science ®Google Scholar
• Pacher P, Ungvári Z, Nánási PP, et al. Electrophysiological changes in rat ventricular and atrial myocardium at different stages of experimental diabetes. Acta Physiol Scand. 1999 May;166(1):7–13.
   PubMedGoogle Scholar
• Watanabe M, Yokoshiki H, Mitsuyama H, et al. Conduction and refractory disorders in the diabetic atrium. Am J Physiol Heart Circ Physiol. 2012 Jul;303(1):H86–95.
   PubMed Web of Science ®Google Scholar
• Kume O, Takahashi N, Wakisaka O, et al. Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats. Heart Rhythm. 2011 Feb;8(2):278–285.
   PubMed Web of Science ®Google Scholar
• Mesubi OO, Anderson ME. Atrial remodelling in atrial fibrillation: caMKII as a nodal proarrhythmic signal. Cardiovasc Res. 2016 Apr 1;109(4):542–557.
   PubMed Web of Science ®Google Scholar
• Daniels LJ, Wallace RS, Nicholson OM, et al. Inhibition of calcium/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats. Cardiovasc Diabetol. 2018 Jun 14;17(1):89.
   PubMed Web of Science ®Google Scholar